イリノイ州における高血圧の臨床試験
イリノイ州内の拠点で、高血圧に関する29件の研究が参加者を募集しています。
イリノイ州内の都市
公式研究テキスト（英語）
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- University of Chicago, Chicago
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT06059638A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Accellacare - DuPage, Lombard
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Cedar Crosse Research Center, Chicago
- Accellacare of Duly - Lombard, Lombard
- Accellacare of Duly, Oak Lawn
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
- Eagle Clinical Research, Chicago
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07511361A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Great Lakes Clinical Trials - Ravenswood, Chicago
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Champaign
- Research Site, Maywood
- Research Site, Rockford
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06742723THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- Ascension Alexian Brothers, Elk Grove Village
- St. John's Prairie Heart, Springfield
- Southern Illinois University, School of Medicine, Springfield
被験者募集中
22歳〜75歳 · 全性別 · 2026/09/24更新 · NCT06559891Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Chicago
- Clinical Trial Site, Chicago
- Clinical Trial Site, Hazel Crest
- 他5件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07181109MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors
- Clinical Nutrition Research Center, Chicago
被験者募集中
40歳〜60歳 · 全性別 · 2026/08/28更新 · NCT06555952Preventative Screening and Health Coaching in a Food Insecure Population
- Rush University Medical Center, Chicago
被験者募集中
40歳〜75歳 · 全性別 · 2026/08/24更新 · NCT06907524Optimizing Sustainable Cuff Access and Training Pathways for Self-Measured Blood Pressure Monitoring in Primary Care
- Advocate Medical Group Chicago (Southeast), Chicago
- Advocate Medical Group Chicago (Imani Village), Chicago
- Advocate Medical Group Beverly, Chicago
- 他3件
被験者募集中
18歳以上 · 全性別 · 2026/08/12更新 · NCT07693699Study of the Progression of Chronic Cardiovascular Conditions
- Prolaio, Chicago
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/12更新 · NCT07420907Global Paradise System US Post Approval Study
- Southern Illinois University, Memorial Medical Center, Springfield
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/12更新 · NCT06297291A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Great Lakes Clinical Trials, Chicago
- AMR Chicago, Niles
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/07/30更新 · NCT07610278An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Eagle Clinical Research, Chicago
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT07543120A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
- Cedar Crosse Research Center, Chicago
被験者募集中
22歳以上 · 全性別 · 2026/07/24更新 · NCT06843577FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
- Mile Square Health Center Chicago, Chicago
- Mile Square Health Center - Auburn Gresham, Chicago
- Mile Square Health Center - Englewood, Chicago
- 他1件
被験者募集中第2相
全年齢 · 全性別 · 2026/07/10更新 · NCT07332741E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control
- Rush University Medical Center, Chicago
被験者募集中
18歳以上 · 全性別 · 2026/06/18更新 · NCT06899750Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
- Prentice Women's Hospital, Chicago
被験者募集中
18歳以上 · 女性 · 2026/05/26更新 · NCT06466161Aspirin and Preeclampsia
- University of Chicago Hospital, Chicago
被験者募集中第4相
18歳〜45歳 · 女性 · 2026/05/04更新 · NCT04479072Mobilizing Community Hypertension Access Pilot
- Rush University Medical Center, Chicago
被験者募集中
18歳以上 · 全性別 · 2026/04/23更新 · NCT07547345Community-based Approach to Lowering Stress Through Mindfulness
- The Salvation Army Ray and Joan Kroc Corps Community Center Chicago, Chicago
被験者募集中
18歳以上 · 全性別 · 2026/04/13更新 · NCT06987799Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Oak Brook
- Vanda Investigative Site, Tinley Park
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/02/27更新 · NCT07090161Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
- University of Chicago, Chicago
被験者募集中観察研究
18歳〜100歳 · 全性別 · 2025/12/16更新 · NCT06039176Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
- University of Chicago Medical Center, Chicago
被験者募集中
18歳〜70歳 · 全性別 · 2025/11/14更新 · NCT06397456Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors
- University of Illinois Chicago, Chicago
被験者募集中
18歳〜99歳 · 女性 · 2025/11/10更新 · NCT06504914bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
- University of Illinois, Urbana-Champaign, Champaign
被験者募集中
60歳以上 · 全性別 · 2025/10/15更新 · NCT06307574Examining Digital Health Care Delivery Models Through Medicaid Collaborative
- OSF HealthCare System, Peoria
被験者募集中観察研究
18歳以上 · 全性別 · 2025/04/30更新 · NCT05555095ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。